Vicriviroc HydrochlorideProduct ingredient for Vicriviroc

Name
Vicriviroc Hydrochloride
Drug Entry
Vicriviroc

Vicriviroc, also known as SCH 417690 and SCH-D, is currently in clinical trials for the management of HIV-1. This pyrimidine based drug inhibits the interaction of HIV-1 with CCR5, preventing viral entry into cells. This drug was developed by Schering-Plough.

Accession Number
DBSALT002033
Structure
Synonyms
Not Available
UNII
25SS1WQB7W
CAS Number
541503-48-4
Weight
Average: 570.1
Monoisotopic: 569.2744377
Chemical Formula
C28H39ClF3N5O2
InChI Key
ULGCLTGMZKAFMX-RIAYWLAYSA-N
InChI
InChI=1S/C28H38F3N5O2.ClH/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3;/h6-9,18-19,24H,10-17H2,1-5H3;1H/t19-,24-;/m0./s1
IUPAC Name
5-{4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methylpiperazin-1-yl]-4-methylpiperidine-1-carbonyl}-4,6-dimethylpyrimidine hydrochloride
SMILES
Cl.COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)C1=C(C)N=CN=C1C)C1=CC=C(C=C1)C(F)(F)F
ChemSpider
8304514
Predicted Properties
PropertyValueSource
Water Solubility0.0362 mg/mLALOGPS
logP3.29ALOGPS
logP2.8Chemaxon
logS-4.2ALOGPS
pKa (Strongest Basic)8.44Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count6Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area61.8 Å2Chemaxon
Rotatable Bond Count7Chemaxon
Refractivity142.64 m3·mol-1Chemaxon
Polarizability56.15 Å3Chemaxon
Number of Rings4Chemaxon
Bioavailability1Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon